CAS 155471-08-2
:JWH-015
Description:
JWH-015 is a synthetic cannabinoid that belongs to a class of compounds known as indole derivatives. It was developed by Dr. John W. Huffman and is known for its high affinity for cannabinoid receptors, particularly CB1 and CB2, which are part of the endocannabinoid system in the human body. This compound is often studied for its potential therapeutic effects, including analgesic and anti-inflammatory properties. JWH-015 is typically encountered in research contexts and is not approved for medical use. It is important to note that synthetic cannabinoids can exhibit unpredictable effects and may pose significant health risks, including psychological and physiological side effects. The substance is often associated with recreational use and has been included in various drug legislation due to its potential for abuse. As with many synthetic cannabinoids, the legal status of JWH-015 varies by jurisdiction, and its use is often subject to regulation.
Formula:C23H21NO
InChI:InChI=1/C23H21NO/c1-3-15-24-16(2)22(20-12-6-7-14-21(20)24)23(25)19-13-8-10-17-9-4-5-11-18(17)19/h4-14H,3,15H2,1-2H3
InChI key:InChIKey=LJSBBBWQTLXQEN-UHFFFAOYSA-N
SMILES:C(=O)(C=1C=2C(N(CCC)C1C)=CC=CC2)C=3C4=C(C=CC3)C=CC=C4
Synonyms:- (2-Methyl-1-Propyl-1H-Indol-3-Yl)-1-Naphthalenylmethanone
- (2-methyl-1-propyl-1H-indol-3-yl)(naphthalen-1-yl)methanone
- Methanone, (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-
- JWH 015
- JWH-015 (1.0mg/ml in Acetonitrile)
- Zinc02577049
- (2-methyl-1-propylindol-3-yl)-naphthalen-1-ylmethanone
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
JWH-015 ((2-Methyl-1-propylindol-3-yl)(naphthalen-1-yl)methanone) 1.0 mg/ml in Acetonitrile
CAS:Controlled ProductColor and Shape:Single SolutionJWH-015 ((2-Methyl-1-propylindol-3-yl)(naphthalen-1-yl)methanone) 0.1 mg/ml in Acetonitrile
CAS:Controlled ProductColor and Shape:Single SolutionJWH-015 ((2-Methyl-1-propylindol-3-yl)(naphthalen-1-yl)methanone)
CAS:Controlled ProductColor and Shape:NeatJWH-015
CAS:Controlled Product<p>Applications A cannabimimetic indole derivative that acts as a CB2 receptor agonist with weak CB2 activity. It has been shown to possess immunomodulatory effects and may be useful in the treatment of pain and inflammation. Synthetic cannabinoids<br>References Aung, M.M. et al.: Drug Alc. Depend., 60, 133 (2000); Ghosh, S. et al.: Mol. Immunol., 43, 2169 (2006); Ehrhart, J. et al.: J. Neuroinflam., 2, 29 (2005); Romero-Sandoval, A. et al.: Anethesiol., 106, 787 (2007);<br></p>Formula:C23H21NOColor and Shape:NeatMolecular weight:327.42JWH-015 (1 mg/ml in Acetonitrile)
CAS:Controlled ProductFormula:C23H21NOColor and Shape:Single SolutionMolecular weight:327.42JWH 015
CAS:Controlled Product<p>JWH 015 is a cannabinoid that binds to the CB2 receptor and activates it, which induces apoptosis in cancer cells. JWH 015 has been shown to be effective against bone cancer, but not against colon cancer. It has also been shown to inhibit the growth of colon cancer cells in vitro by inhibiting the proliferation of cells and inducing apoptosis. JWH 015 may have potential as a chemotherapeutic agent for treating colorectal cancers. It does not bind to the CB1 receptors found on neurons and so does not cause any psychoactive effects.</p>Formula:C23H21NOPurity:Min. 95%Molecular weight:327.42 g/mol



